The goal of the proposed research is to investigate the nature of molecules on the surface of islet cells that may be antigenic in the pathogenesis of Type I Diabetes. It is not known whether the islet cell antigen is a normal product of the beta cell or whether it is the result of an environmental agent, such as a virus. The hypothesis to be tested in this project is that the antigen is a molecule normally present on islet beta cells.
The specific aims of this project are: 1. Develop antibodies to islet cells by induction of diabetes in autoimmune mice using the diabetogenic drug, streptozotocin, and by selection of auto-antibodies to islets in the diabetic NOD mouse. Mice judged to be making antibodies to islet cells will be used in the production of monoclonal antibodies. 2. Characterize monoclonal antibodies obtained in Specific Aim No. 1 with regard to the molecules they recognize on islet cells. The antibodies will be defined by their ability to bind islet cells, by the products they immunoprecipitate from islet cells, and by their ability to affect disease transfer or graft rejection experiments. 3. Develop T cell lines specific for islet cells by isolating T cells primed for islet antigens. These cells would be obtained from spleen and/or lymph node cells of diabetic mice or from grafts of islet tissue in diabetic mice. T cells from these sources that proliferate in response to islet antigen and antigen-presenting cells will be used to established permanent lines of islet-specific T cells.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Peterson, J D; Haskins, K (1996) Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 45:328-36
Sellins, K S; Gold, D P; Bellgrau, D (1996) Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens. Diabetologia 39:28-36
Peterson, J D; Pike, B; Dallas-Pedretti, A et al. (1995) Induction of diabetes with islet-specific T-cell clones is age dependent. Immunology 85:455-60
Gold, D P; Shaikewitz, S T; Mueller, D et al. (1995) T cells from BB-DP rats show a unique cytokine mRNA profile associated with the IDDM1 susceptibility gene, Lyp. Autoimmunity 22:149-61
Bergman, B; Haskins, K (1994) Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43:197-203
Peterson, J D; Pike, B; McDuffie, M et al. (1994) Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J Immunol 153:2800-6
Bellgrau, D; Redd, J M; Sellins, K S (1994) Peculiar T-cell signaling does not preclude positive selection in the diabetes-prone BB rat. Diabetes 43:47-52
Shehadeh, N N; Gill, R G; Lafferty, K J (1993) Mechanism of self-tolerance to endocrine tissue. Springer Semin Immunopathol 14:203-20
Hayward, A R; Shriber, M; Cooke, A et al. (1993) Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. J Autoimmun 6:301-10
Shehadeh, N N; LaRosa, F; Lafferty, K J (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300

Showing the most recent 10 out of 29 publications